Atlastin-1 (ATL1), also known as SPG3A or HSpL1, is a membrane-anchored GTPase that plays essential roles in endoplasmic reticulum (ER) morphology, membrane trafficking, and neuronal development. Mutations in ATL1 cause hereditary spastic paraplegia type 3A (SPG3A), a neurodegenerative disorder characterized by progressive lower limb spasticity and weakness. Beyond hereditary spastic paraplegia (HSP), ATL1 dysfunction contributes to axonal degeneration in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions. This protein represents a critical nexus between ER biology, axonal transport, and neurodegeneration 1.
:: infobox .infobox-protein
| Protein Name | Atlastin-1 (ATL1) |
| Gene | ATL1 |
| UniProt | Q9Y2K2 |
| Molecular Weight | ~56 kDa |
| Subcellular Localization | Endoplasmic reticulum membrane |
| Protein Family | Atlastin/Sey1p GTPase family |
| Tissue Expression | Neurons (corticospinal tract), all tissues |
::
Atlastin-1 is one of three mammalian atlastin proteins (ATL1, ATL2, ATL3) that mediate ER membrane fusion and tubulation. The atlastin family is conserved from yeast (Sey1p) to humans, reflecting the fundamental importance of ER morphology for cellular function 2.
¶ Structure and Domain Architecture
Atlastin-1 is a tail-anchored GTPase with unique structural features:
¶ N-Terminal GTPase Domain (Amino Acids 1-300)
The N-terminal region contains:
- GxxxxGKST motif (Walker A): Phosphate-binding loop for GTP
- Switch I region: Conformational change upon GTP hydrolysis
- Switch II region: Critical for catalysis and interdomain movements
- GTPase catalytic core: Mediates GTP hydrolysis to GDP
The GTPase domain faces the cytosol and undergoes dimerization-dependent conformational changes. The catalytic mechanism involves GTP hydrolysis driving a power stroke that pulls membranes together 3.
- Single transmembrane helix: Spans ER membrane at ~25 nm from the cytosolic side
- C-terminal tail: Cytosolic orientation, contains GTPase domain
- Cysteine palmitoylation: S-acylation for membrane localization
- Luminal loop: Short 10-amino acid loop facing ER lumen
- HRD motif: Catalytic residue for GTP hydrolysis
- Nucleotide-sensitive dimerization: GTP-bound dimers vs GDP-bound monomers
- Cross-steamer mechanism: Drives membrane fusion through conformational changes
ATL1 controls ER network architecture:
- ER tubule formation: GTP-driven membrane curvature
- Network maintenance: Polymerization at three-way junctions
- ER sheet formation: Generates flat cisternal membranes
- Dynamic remodeling: Responds to cellular demands
The atlastin-mediated ER network is essential for:
- Protein synthesis and folding
- Lipid metabolism
- Calcium storage
- Organelle contact sites 4
ATL1 regulates vesicular transport:
- COPII trafficking: ER to Golgi transport
- ER-Golgi intermediate compartment (ERGIC): Forms transport carriers
- Autophagy initiation: ER serves as phagophore assembly site
- Axonal secretory pathway: Delivers proteins to distal axons
In neurons, ATL1 is essential for:
- Axon growth: Developmental and regenerative outgrowth
- Synapse formation: Delivery of synaptic components
- Axonal transport: ER dynamics in long axons
- Myelin maintenance: Oligodendrocyte ER function
ATL1 mutations cause autosomal dominant HSP:
- GTPase domain mutations: Reduce hydrolysis activity
- Dimerization defects: Impair membrane fusion
- ER morphology disruption: Abnormal ER networks in neurons
- Axonal degeneration: Corticospinal tract vulnerability
SPG3A is one of the most common forms of pure HSP, accounting for ~10% of all cases. Patients present with progressive lower limb spasticity and hyperreflexia, typically beginning in childhood or early adulthood 5.
| Mutation Type |
Severity |
Phenotype |
| GTPase domain (R239C) |
Early-onset, severe |
Pure HSP |
| Dimerization (R495Q) |
Adult-onset |
Complicated HSP |
| Transmembrane (P361L) |
Variable |
HSP with neuropathy |
| N-terminal (P361L) |
Childhood onset |
SPG3A with thin corpus callosum |
- GTPase activators: Enhance residual ATL1 activity
- ER stress modulators: Reduce unfolded protein response
- Neurotrophic factors: Support axonal survival
- Gene therapy: Wild-type ATL1 delivery via AAV
¶ ER Stress and AD Pathogenesis
ATL1 dysfunction contributes to AD through:
- UPR activation: Chronic ER stress promotes tau pathology
- Calcium dysregulation: Alters ER calcium stores
- APP processing: Affects amyloidogenic cleavage
- Synaptic dysfunction: Impairs synaptic protein trafficking 6
In AD:
- Tau pathology: ATL1 dysfunction exacerbates transport deficits
- Mitochondrial trafficking: Impaired along microtubules
- Synaptic vesicle delivery: Reduced neurotransmitter release
- Sterol transport: Alters membrane composition
- ATL1 expression altered in AD brain
- ER stress markers elevated in AD neurons
- ATL1 variants modify AD risk in genome-wide studies
ATL1 in PD:
- ER-Golgi trafficking: α-Syn oligomers disrupt transport
- Calcium homeostasis: ATL1 dysfunction sensitizes neurons
- Mitochondrial quality control: ER-mitochondria contacts impaired
- Lewy body formation: ER stress contributes to aggregation 7
- ATL1 expression reduced in PD substantia nigra
- ER stress markers elevated in PD patients
- ATL1 variants modify PD risk
ATL1 in ALS:
- Distal axon vulnerability: Longest axons most affected
- ER dynamics: Impaired in ALS models
- Protein aggregation: ER stress promotes inclusion formation
- Axonal transport: Critical for neuromuscular junction
ATL1 interacts with:
- SOD1: Mutant SOD1 disrupts ER function
- C9orf72: Regulates ER trafficking
- TDP-43: Aggregates in ER compartments
ATL1 mutations cause CMT2:
- Distal axon degeneration: Length-dependent neuropathy
- Sensory dysfunction: Loss of proprioception
- Motor weakness: Foot drop and hand weakness
- ER homeostasis: Critical for long axons 8
ATL1 regulates interorganelle communication:
- MAM formation: Mitochondria-associated membranes
- Calcium transfer: ER to mitochondria Ca²⁺ signaling
- Lipid exchange: Phospholipid trafficking
- Apoptosis regulation: Cytochrome c release
- VAPB: ER anchor for MCS
- PTPIP51: Mitochondrial tether
- Mfn1/2: Mitochondrial dynamics
The axonal ER is specialized:
- Tubular network: Extends throughout axons and dendrites
- Ribosome-free: Smooth ER in distal processes
- Calcium stores: Regulates neuronal signaling
- Synaptic regions: High density of ER-PM contacts
- Calcium microdomains: Localized Ca²⁺ signaling
- Membrane trafficking: Exocytosis and endocytosis
| Interacting Protein |
Interaction Type |
Functional Outcome |
| ATL2 |
Heterodimer |
ER network formation |
| ATL3 |
Heterodimer |
Peripheral nerve function |
| REEP proteins |
Tubulation |
ER shaping |
| Spastin |
Co-localization |
ER-microtubule contact |
| RTN1/2/3 |
Complex |
ER morphology |
| p115 |
Transport |
COPII vesicle tethering |
| GM130 |
Golgi |
ER-Golgi transport |
| VAPB |
ER contacts |
Lipid exchange |
| Protrudin |
Axonal ER |
Neurite outgrowth |
| Rab11 |
Recycling endosomes |
Secretory trafficking |
| STIM1 |
Calcium sensing |
Store-operated entry |
| ORP1L |
Lipid transport |
MCS formation |
ATL1 activates:
- IRE1 pathway: XBP1 splicing
- PERK pathway: eIF2α phosphorylation
- ATF6 pathway: Transcription factor cleavage
- ER Ca²⁺ release activates store-operated channels
- ATL1 mutants alter calcium homeostasis
- Calcium dysregulation contributes to neurodegeneration
- SREBP pathway: Regulates ATL1 expression
- PI4P metabolism: Affects ER-Golgi trafficking
- Phosphatidylserine: Important for ER morphology
- ATL1: Neuron-specific functions
- ATL2: Ubiquitous, ER morphology
- ATL3: Peripheral nerve function
- High sequence conservation
- Functional conservation
- Disease models applicable
- Atl1⁻/⁻ mice: Embryonic lethal, ER formation defects 9
- Atl1ΔC mutant: HSP-like phenotype in mice
- Zebrafish models: Motor axon guidance defects
- Drosophila: Conserved ER morphology function
- GTPase modulators: Enhance ATL1 GTP hydrolysis
- ER stress inhibitors: TUDCA, sodium phenylbutyrate
- Neuroprotective compounds: BDNF, CNTF
- Autophagy enhancers: Rapamycin, trehalose
- AAV-delivered wild-type ATL1: Restore function
- CRISPR base editing: Correct pathogenic mutations
- RNAi knockdown: If toxic gain-of-function
- ATL1 overexpression: Enhance ER function
- Dominant-negative mutations difficult to treat
- CNS delivery challenging
- Long axons require distal targeting
- Timing of intervention critical
ATL1 as a biomarker:
- CSF ATL1 levels: Potential neurodegeneration marker
- ER stress markers: CHOP, BiP in blood
- Neurofilament light: Axonal damage marker
- Imaging: ER morphology in living patients 10
Atlastin-1 represents a critical ER GTPase whose dysfunction causes hereditary spastic paraplegia and contributes to axonal degeneration in AD, PD, and ALS. Its essential role in ER morphology, membrane trafficking, and axonal biology makes it an important therapeutic target. Further research into ATL1 biology will illuminate mechanisms of axonal vulnerability and identify treatment strategies for these devastating disorders.